NCT02521311: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- State
- Under way
- Phase
- Phase 2
- People
- 90 planned
- Started
- 28 Feb 2017
- Primary completion
- Aug 2028
- Arms
- Clemastine
- Results
- None posted
- 13 Aug 2015: Trial registered
- 28 Feb 2017: Trial started